Home › Funds › MAK CAPITAL ONE LLC › CAI
MAK CAPITAL ONE LLC position in CAI
CARIS LIFE SCIENCES INC · Health Care
MAK CAPITAL ONE LLC reported holding 2,152,433 shares of CAI (CARIS LIFE SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$65.9M, representing 10.53% of its reported portfolio and ranking #3 among its reported holdings. MAK CAPITAL ONE LLC has disclosed CAI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MAK CAPITAL ONE LLC's CAI position evolved
MAK CAPITAL ONE LLC first disclosed a stake in CAI in Q2 2026 at 1,937,229 shares (US$34.5M). The position peaked in Q3 2026 at 2,152,433 shares, worth US$65.9M. Across 2 filings, MAK CAPITAL ONE LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,152,433 shares valued at US$65.9M — an increase of 215,204 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.94M | $34.52M | New |
| Q3 2026 | 2.15M | $65.93M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAI and 13F data
CAI (CARIS LIFE SCIENCES INC) is a Health Care company. 66 other funds we track also report a position in CAI — the largest reported positions include D. E. Shaw & Co., Inc. (US$221.1M), Coatue Management (US$175.0M), Sixth Street Partners Management Company, L.P. (US$92.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAI
- D. E. Shaw & Co., Inc. 7.22M sh · $221.10M · Q3 2026
- Coatue Management 9.82M sh · $174.99M · Q2 2026
- Sixth Street Partners Management Company, L.P. 3.03M sh · $92.89M · Q3 2026
- BRAIDWELL LP 2.75M sh · $84.13M · Q3 2026
- ORBIMED ADVISORS LLC 2.19M sh · $67.17M · Q3 2026
- J. H. Whitney Equity Partners VI, LLC 1.75M sh · $53.62M · Q3 2026
- Champlain Investment Partners, LLC 1.05M sh · $32.28M · Q3 2026
- ZEVENBERGEN CAPITAL INVESTMENTS LLC 719.60K sh · $22.04M · Q3 2026
- Rock Springs Capital Management LP 438.50K sh · $13.43M · Q3 2026
- Pembroke Management, LTD 299.79K sh · $9.18M · Q3 2026
- Wealth High Governance Asset Management Ltda. 229.36K sh · $7.03M · Q3 2026
More on MAK CAPITAL ONE LLC
FAQ
How long has MAK CAPITAL ONE LLC held CAI?
MAK CAPITAL ONE LLC has disclosed CAI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is MAK CAPITAL ONE LLC's current position in CAI?
As of Q3 2026, MAK CAPITAL ONE LLC holds 2.15M shares of CAI (CARIS LIFE SCIENCES INC), valued at $65.93M, representing 10.53% of its reported portfolio and ranking #3.
Has MAK CAPITAL ONE LLC been buying or selling CAI?
In the latest 13F filing (Q3 2026), MAK CAPITAL ONE LLC increased its position in CAI. The position peaked in Q3 2026 at 2.15M shares.
Which other funds hold CAI?
Other major institutional holders of CAI include D. E. Shaw & Co., Inc., Coatue Management, Sixth Street Partners Management Company, L.P., among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.